SANDALOVA, Sofya; DAL, Uğur; SANDALOV, Arseniy. Early Post-Marketing Safety Signals of Anifrolumab in EudraVigilance: A Belimumab-Comparator Disproportionality Analysis. International Journal of Medical Students, [S. l.], 2026. Disponível em: https://ijms.info/IJMS/article/view/4785. Acesso em: 30 aug. 2026.